Characterization of antibodies to SARS-CoV-2 in lyophilized plasma prepared with amotosalen-UVA pathogen reduction.
Christophe MartinaudAnil BagriCheng-Ting TsaiRafael R de AssisMichelle GatmaitanPeter V RobinsonDavid SeftelSaahir KhanPhilip L FelgnerLaurence M CorashPublished in: Transfusion (2023)
The antibody activity in pooled pathogen-reduced lyophilized CCPs demonstrated minimal impact due to pathogen reduction treatment and lyophilization.